This whitepaper is brought to you by Imaging Endpoints.

Hi E, check out thisfree whitepaperwe think you'll like:

Whitepaper: How Does Imaging Support the Development of New Therapeutics: A Focus on ADC and Radioisotope Therapy

Advanced medical imaging is transforming the development of antibody-drug conjugates (ADCs) and radioisotope therapies (RITs), enabling more effective targeting of tumor cells while minimizing damage to healthy tissue. This resource explores how imaging technologies enhance clinical trial design, accelerate drug approvals, and improve patient access to groundbreaking treatments. It also delves into key considerations for determining the suitability of ADCs or RITs based on specific molecules and patient profiles.

• How advanced imaging supports ADC and RIT development.
• The role of imaging in speeding up clinical trials and approvals.
• Insights into choosing between ADCs and RITs for specific applications.